Enzymic Depolymerization of Macromolecular Heparin as a Factor in Control of Lipoprotein Lipase Activity

AUTOR(ES)

Horner, Alan A.

RESUMO

Macromolecular heparin from rat skin shows poor lipoprotein lipase-releasing activity in vivo and is a potent inhibitor of rat-heart lipoprotein lipase in vitro. Rat-skin heparin is depolymerized by incubation with the 100,000 × g supernatant from a sonicated homogenate of rat small intestine. The depolymerized products, fractionated by gel filtration, range from inhibitors to activators of lipoprotein lipase as molecular size decreases. Depolymerized rat heparin in the same molecular size range as commercial heparin from pig intestinal mucosa has about two-thirds the activity of the commercial preparation, both in vivo and in vitro.

Documentos Relacionados

• Lipoprotein lipaseBethesda: a single amino acid substitution (Ala-176----Thr) leads to abnormal heparin binding and loss of enzymic activity.
• Effects of heparin on the uptake of lipoprotein lipase in rat liver
• Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
• Effect of heparin on the inactivation of serum lipoprotein lipase by the liver in unanesthetized dogs
• Heparin-binding defective lipoprotein lipase is unstable and causes abnormalities in lipid delivery to tissues